Traws Pharma (TRAW) Tops Q1 EPS by 209c

Traws Pharma (NASDAQ: TRAW) reported Q1 EPS of $2.09. Revenue for the quarter came in at $60 thousand.

For earnings history and earnings-related data on Traws Pharma (TRAW) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform